Literature DB >> 10884396

Transforming growth factor beta contributes to progressive diabetic nephropathy.

W B Reeves1, T E Andreoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10884396      PMCID： PMC33997          DOI： 10.1073/pnas.97.14.7667

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  40 in total

Review 1.  Going mad with Smads.

Authors:  S Zhou; K W Kinzler; B Vogelstein
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

Review 2.  Specificity, diversity, and regulation in TGF-beta superfamily signaling.

Authors:  E Piek; C H Heldin; P Ten Dijke
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

Review 3.  Role of transforming growth factor beta in human disease.

Authors:  G C Blobe; W P Schiemann; H F Lodish
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

4.  Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy.

Authors:  F Lang; K Klingel; C A Wagner; C Stegen; S Warntges; B Friedrich; M Lanzendorfer; J Melzig; I Moschen; S Steuer; S Waldegger; M Sauter; M Paulmichl; V Gerke; T Risler; G Gamba; G Capasso; R Kandolf; S C Hebert; S G Massry; S Broër
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 5.  The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

Authors:  R E Gilbert; M E Cooper
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

6.  Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients.

Authors:  K Sharma; B O Eltayeb; T A McGowan; S R Dunn; B Alzahabi; R Rohde; F N Ziyadeh; E J Lewis
Journal:  Am J Kidney Dis       Date:  1999-11       Impact factor: 8.860

Review 7.  End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.

Authors:  E Ritz; I Rychlík; F Locatelli; S Halimi
Journal:  Am J Kidney Dis       Date:  1999-11       Impact factor: 8.860

8.  Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

Authors:  F N Ziyadeh; B B Hoffman; D C Han; M C Iglesias-De La Cruz; S W Hong; M Isono; S Chen; T A McGowan; K Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

9.  Glomerular hemodynamics in experimental diabetes mellitus.

Authors:  T H Hostetter; J L Troy; B M Brenner
Journal:  Kidney Int       Date:  1981-03       Impact factor: 10.612

10.  Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.

Authors:  C E Mogensen
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245
View more
  65 in total

Review 1.  Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome.

Authors:  Jun Oh; Jochen Reiser; Peter Mundel
Journal:  Pediatr Nephrol       Date:  2003-12-13       Impact factor: 3.714

2.  Regulation of type II transforming-growth-factor-beta receptors by protein kinase C iota.

Authors:  Lea-Yea Chuang; Jinn-Yuh Guh; Shu-Fen Liu; Min-Yuan Hung; Tung-Nan Liao; Tai-An Chiang; Jau-Shyang Huang; Yu-Lun Huang; Chi-Fong Lin; Yu-Lin Yang
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

3.  Epigenetic histone methylation modulates fibrotic gene expression.

Authors:  Guangdong Sun; Marpadga A Reddy; Hang Yuan; Linda Lanting; Mitsuo Kato; Rama Natarajan
Journal:  J Am Soc Nephrol       Date:  2010-10-07       Impact factor: 10.121

4.  Renoprotective effects of anti-TGF-β antibody and antihypertensive therapies in Dahl S rats.

Authors:  Sydney R Murphy; Annette J Dahly-Vernon; Kathryn M J Dunn; Chun Cheng Andy Chen; Steven R Ledbetter; Jan M Williams; Richard J Roman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-04-25       Impact factor: 3.619

5.  Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy.

Authors:  Harmeet Kaur; Alexander Chien; Ishwarlal Jialal
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-08

Review 6.  New molecular insights in diabetic nephropathy.

Authors:  Ionel Alexandru Checheriţă; Gina Manda; Mihai Eugen Hinescu; Ileana Peride; Andrei Niculae; Ştefana Bîlha; Angelica Grămăticu; Luminiţa Voroneanu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

7.  Next-generation sequencing identifies TGF-β1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathy.

Authors:  Eoin P Brennan; Melissa J Morine; David W Walsh; Sarah A Roxburgh; Maja T Lindenmeyer; Derek P Brazil; Peadar Ó Gaora; Helen M Roche; Denise M Sadlier; Clemens D Cohen; Catherine Godson; Finian Martin
Journal:  Biochim Biophys Acta       Date:  2012-01-14

8.  Development of antisense oligonucleotide (ASO) technology against Tgf-β signaling to prevent scarring during flexor tendon repair.

Authors:  Alayna E Loiselle; Kiminori Yukata; Michael B Geary; Sirish Kondabolu; Shanshan Shi; Jennifer H Jonason; Hani A Awad; Regis J O'Keefe
Journal:  J Orthop Res       Date:  2015-06       Impact factor: 3.494

9.  Heterozygous knockout of transforming growth factor-β1 protects Dahl S rats against high salt-induced renal injury.

Authors:  Chun Cheng Andy Chen; Aron M Geurts; Howard J Jacob; Fan Fan; Richard J Roman
Journal:  Physiol Genomics       Date:  2012-12-18       Impact factor: 3.107

Review 10.  New insights into molecular mechanisms of diabetic kidney disease.

Authors:  Shawn S Badal; Farhad R Danesh
Journal:  Am J Kidney Dis       Date:  2014-02       Impact factor: 8.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.